BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Change in Directorate
Appointment of Ms. Naina Lal Kidwai as an Additional Director (Independent Director) of the Company.28-04-2022
28-04-2022
BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Change in Directorate
Appointment of Ms. Naina Lal Kidwai as an Additional Director (Independent Director) of the Company.28-04-2022
BIOCON LTD. - 532523 - Board Meeting Outcome for Financial Results For The Quarter And Year Ended March 31, 2022
Financial Results for the quarter and year ended March 31, 202228-04-2022
BIOCON LTD. - 532523 - Financial Results For The Quarter And Year Ended March 31, 2022.
Financial Results for the quarter and year ended March 31, 2022.28-04-2022
BIOCON LTD. - 532523 - Change In Name Of Company''s Registrar And Share Transfer Agent
The name of the Company's Registrar and Share Transfer Agent (RTA) has been changed from 'KFin Technologies Private Limited' to 'KFin Technologies Limited' with effect from February 24, 2022. In view of the above, we request you to take note of the same and update the name of "KFin Technologies Limited" as the RTA of the Company in your records.27-04-2022
Biocon Biologics bags $90 million contract from Malaysia govt
Their Insugen formulations will be available at govt hospitals, district health offices, health clinics in Malaysia26-04-2022
BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Biocon Biologics' Insugen(r) Awarded a Three-Year Contract by Ministry of Health, Malaysia26-04-2022
BIOCON LTD. - 532523 - Statement Of Investor Complaints For The Quarter Ended March 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 039381 Name of the Signatory :- Mayank VermaDesignation :- Company Secretary and Compliance Officer19-04-2022
BIOCON LTD. - 532523 - Compliance Certificate Under Regulation 7 (3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended March 31, 2022.
With reference to the above subject, we hereby confirm that activities in relation to both physical and electronic share transfer facilities were maintained during the period October 1, 2021 to March 31, 2022 (both days inclusive) by KFin Technologies Limited (Formerly known as KFin Technologies Private Limited), Registrar and Share Transfer Agent ('RTA') of the Company, which is registered as Registrar & Share Transfer Agent in Category-I with the Securities and Exchange Board of India vide Registration Number: INR000000221. A half yearly Compliance Certificate under Regulation 7(3) of the SEBI Listing Regulations, 2015 dated April 6, 2022 issued by KFin Technologies Limited affirming the same is enclosed herewith.14-04-2022
BIOCON LTD. - 532523 - Compliance Certificate Under Regulation 40 (9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended March 31, 2022.
With reference to the above subject, please find enclosed the Compliance Certificate under Regulation 40(9) of SEBI Listing Regulations, issued by Mr. Pradeep B Kulkarni, Practicing Company Secretary with regard to transfer/ sub-division/ consolidation/ renewal/ exchange or endorsement of calls/ allotment of monies for the year ended March 31, 2022.14-04-2022